NEWS & EVENTS
Press Releases • May 16, 2012
In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own – for the first time in nearly 15 years – by using her thoughts to direct a robotic arm. The trial, funded in part by the National Institutes of Health, is evaluating the safety and feasibility of an investigational device called the BrainGate neural interface system. This is a type of brain-computer interface (BCI) intended to put robotics and other assistive technology under the brain's control.
Grantee News • May 2, 2012
Nicole Steinmetz, Ph. D., NIBIB grantee and researcher at Case Western Reserve University uses plant virus nanoparticles to attack brain and breast tumors, as well as colon and prostate cancer. Read the full article from WKYC News.
Science Highlights • April 30, 2012
After three decades of research in animals, scientists have tested a new therapy for paralysis in a person with spinal cord injury. The therapy is based on the notion that the spinal cord controls walking even when communication with the brain is cut off.
Grantee News • April 27, 2012
Rebecca Richards-Kortum, Ph. D., a long-term NIBIB grantee and Stanley C. Moore Professor of Bioengineering at Rice University, together with her colleagues recently won the Science prize for Inquiry Based Instruction by challenging students to find novel technical solutions to global health problems. Read the full article from Science.
Press Releases • April 4, 2012
To help foster the next generation of global health scientists, Fogarty International Center and its partners at the National Institutes of Health are building a network of U.S. academic institutions to provide early-career physicians, veterinarians, dentists and scientists with a significant mentored research experience in a developing country.
Press Releases • April 2, 2012
Researchers at the National Institutes of Health Clinical Center discovered a way to enhance delivery of transplant cells in rodents to a desired site by increasing presence of chemicals that attract the introduced cells. Non-destructive pulsed focused ultrasound interacts with tissue to elevate levels of naturally produced chemicals (such as cytokines, chemokines, and growth factors) on target tissues. Transplanted stem cells have receptors for these chemicals, so an increased presence attracts more of them to the desired site.
A four-year NIBIB-funded study of 146 patients with flu-like symptoms has validated a prototype rapid, low-cost, accurate, point-of-care device which could provide clinicians with an effective tool to quickly diagnose both seasonal and pandemic strains of influenza, and thus limit the spread of infection. Read the full article from Boston University.
Press Releases • March 6, 2012
Researchers have developed a method to label transplanted cells so they can be tracked by magnetic resonance imaging (MRI). In the future, as cell therapies become a more integral part of regenerative medicine and tumor treatment, there could be increased need to measure how many transplanted immune or stem cells reach their target.
Grantee News • March 1, 2012
With a grant from the NIBI, the team of Adam Maxwell, Charles Cain, Hitinder Gurm, and Zhen Xu at the University of Michigan are investigating the use of histotripsy (surgical technique using high intensity ultrasound for fractionation of tissues) to breakdown clots for the non-invasive treatment of deep vein thrombosis. Read the full article from Medical Design Briefs.
Science Highlights • February 29, 2012
Prostate cancer is the most common cancer and the second leading cause of cancer-related death in men. Successful treatment of prostate cancer relies in part on its early and accurate detection. Conventional prostate imaging approaches including ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) are not sensitive enough to detect very small tumors in the prostate or signs that the disease has metastasized (spread). A new class of agents known as viral nanoparticles offers the opportunity to improve detection of small lumps of cancer cells.